Sales and Marketing

Showing 15 posts of 11465 posts found.

Sun Pharma and Pharmazz enter license agreement for Tyvalzi in India

September 14, 2023 Sales and Marketing License Agreement, Neurology, Pharmazz, Sun Pharma, Tyvalzi, sovateltide

Sun Pharma has announced that one of its wholly owned subsidiaries has entered into a license agreement with Pharmazz in …

AbbVie’s Aquipta receives MHRA marketing authorisation

September 5, 2023 Sales and Marketing AbbVie, Aquipta, MHRA, Neurology, atogepant, migraines

AbbVie has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing authorisation for Aquipta (atogepant), …

Takeda and ImmunoGen collaborate for development and commercialisation of Elahere in Japan

August 29, 2023 Sales and Marketing Elahere, Immunogen, Oncology, Takeda

ImmunoGen has announced that it has entered into an exclusive collaboration with Takeda Pharmaceutical Company for the development and commercialisation …

Amarin gains positive opinion from Spanish Drug Pricing Committee for national reimbursement of Vazkepa in Spain

July 26, 2023 Sales and Marketing Amarin, Cardiology, Spanish Drug Pricing Committee, Vazkepa, cardiovascular

Amarin has announced that the Spanish Drug Pricing Committee has recommended the national reimbursement of Vazkepa (icosapent ethyl) in Spain …

BioIVT acquires PrecisionMed for neurology and oncology research

July 21, 2023 Sales and Marketing Neurology, Oncology, neurology, oncology

BioIVT has announced that it has acquired PrecisionMed, a leading supplier of high-quality human biological material for genetics, drug discovery …

Eli Lilly to acquire Versanis Bio for $1.9bn

July 17, 2023 Sales and Marketing Cardiology, Eli Lilly, Versanis Bio, acquisition, cardiometabolic diseases

Eli Lilly and Versanis Bio have announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company …

Nanobiotix announces license agreement with Janssen for development and commercialisation of new cancer treatment

July 10, 2023 Sales and Marketing Cancer, Janssen, License Agreement, Oncology, nanobiotix

Nanobiotix has announced a global licensing, co-development and commercialisation agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies …

XOMA acquires royalty and milestone rights for NPC and pancreatic cancer assets

June 23, 2023 Sales and Marketing Cancer, Oncology, Xoma, acquisition, oncology

US-based biotechnology royalty aggregator XOMA has announced that it has gained the royalty and milestone rights for two assets from …

Report finds NHS may miss out on new drugs due to rising costs

June 5, 2023 Sales and Marketing LSE, LSHTM, NHS, Pharmacy, University of York, drug prices

Figures from a team at the University of York, the London School of Economics and Political Science (LSE) and the …

Pharmanovia and Stealth BioTherapeutics enter new licensing agreement for novel Barth syndrome treatment

May 31, 2023 Sales and Marketing Barth syndrome, Cardiology, Pharmanovia, Stealth BioTherapeutics, licensing agreement

Pharmanovia and Stealth BioTherapeutics have announced that they have entered into a new licensing agreement for the marketing and further …

ElevateBio announced $401m in Series D financing for cell and gene therapies

May 25, 2023 Sales and Marketing ElevateBio, Financing, cell and gene therapies

US-based cell and gene therapy (CGT) company ElevateBio has announced that, at the end of its Series D financing led …

Oncimmune Holdings sells businesses to Freenome in £13m deal

May 22, 2023 Sales and Marketing Freenome, Oncimmune Holdings, Oncology, acquisition

UK-based life sciences and immunodiagnostics firm Oncimmune Holdings has announced that it has sold its Oncimmune Limited and Oncimmune Europe …

Nido Biosciences raises $109m in funding for neurological diseases treatments

May 16, 2023 Sales and Marketing Financing, Neurology, Nido Biosciences, funding, neurology

US-based clinical-stage company Nido Biosciences has announced that is has received $109m in Seed, Series A and Series B financings, …

uniQure announces sale of royalty interest in Hemgenix for up to $400m

May 16, 2023 Sales and Marketing Haematology, Hemgenix, haemophilia, royalties, uniQure

uniQure has announced that it has entered a definitive agreement to sell a portion of the royalty rights due to …

Angelini Pharma and JCR Pharmaceuticals partner to develop new epilepsy therapies

May 12, 2023 Sales and Marketing Angelini Pharma, JCR Pharmaceuticals, Neurology, epilepsy

Angelini Pharma and JCR Pharmaceuticals have announced that they have entered into an exclusive global development and commercialisation agreement for …

Latest content